HaloTag® Technology: Focus on Fluorescent Imaging with DMSO-Soluble Ligands Technical Manual
Instructions for Use of Product(s)
G2991, G3221, G1001, G1002, G2801, G2802, G8251, G8252, G8272, G8273, G8581, G8582, G9281, G8471, G8472, G9211, GA1110, GA1111, GA1120, GA1121
Literature # TM260
The HaloTag® Interchangeable Labeling Technology is a novel tool for imaging live or fixed mammalian cells that express the HaloTag® protein or protein fusions, analyzing posttranslational modification of labeled fusion proteins, and isolating proteins and protein complexes. The technology is based on efficient formation of a covalent bond between the HaloTag® reporter protein and a specific ligand in living cells, in solution or on a solid support. The HaloTag® protein is not endogenous to mammalian cells.
The HaloTag® ligands carry a variety of functionalities, including fluorescent labels, affinity handles and attachments to a solid phase. The covalent bond forms rapidly under general physiological conditions and is highly specific and essentially irreversible, yielding a complex that is stable even under stringent conditions. The open architecture of the technology enables use of different ligands. We currently offer ligands that can readily cross the cell membrane with blue, red or green fluorophores or biotin. We also offer the cell-impermeant HaloTag® Alexa Fluor® 488 Ligand for labeling cell-surface HaloTag® protein fusions. Additional ligands will be offered to expand the range of applications, as well as solid supports for direct capture of the HaloTag® protein or protein fusions.
Summary of Changes
The following changes were made to the 10/24 revision of this document:
1. Removed the HaloTag® Building Blocks and 1nmol Janelia Fluor® and Janelia Fluor® JFX HaloTag® Ligands.
2. Updated Figure 2.
3. Deleted Sections 2.B, 4.D and 6, renumbering the subsequent sections and figures.
4. Edited Step 1 for Sections 4.E, 4.F and 4.G.
5. Updated Sections 8.A, 8.C, 8.D and 9.
6. Revised the document title.
7. Update disclaimers and patent statements.
Revised 10/24.
